Austin, TX
Migraine Treatment clinics in Austin
Austin has 6 providers offering migraine care, spanning conventional neurology and regenerative or integrative options. The conventional stack includes triptans, CGRP inhibitors like Aimovig, Emgality, Ajovy, and Nurtec ODT, and onabotulinumtoxinA (Botox) for chronic migraine, which is FDA-approved for that indication. On the regenerative and device side, eNeura's sTMS mini is FDA-cleared for acute and preventive treatment of migraine with aura. Occipital and sphenopalatine ganglion nerve blocks are commonly used off-label in Austin clinics, typical cost 150 to 400 dollars per injection. PRP scalp injections and neurofeedback are offered by some integrative practices, though evidence for PRP in migraine is Insufficient. Texas insurers generally cover CGRP inhibitors and Botox for chronic migraine (15 or more headache days per month) when step therapy is documented. A reputable Austin migraine clinic will start with a neurology evaluation, headache diary, and imaging when red flags are present before escalating to device or procedural options.
Texas Spine and Sports Therapy Center
- PRP Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Migraine Treatment
- Stem Cell Therapy
Loyal IV Clinic
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Arthritis Treatment
- Migraine Treatment
Austin Red Light Therapy
- Acne Treatment
- Arthritis Treatment
- Migraine Treatment
- Red Light Therapy
- Psoriasis Treatment
Hormone Wellness Center
- Migraine Treatment
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
Dr. Erica Rivas de Srinivasa
- IV Therapy
- Transcranial Magnetic Stimulation (TMS)
- Multiple Sclerosis (MS) Treatment
- Migraine Treatment
Elite Medical + Longevity
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Migraine Treatment
Alchemy Collective
- PRP Therapy
- Ketamine Therapy
- Arthritis Treatment
- Migraine Treatment
- Hormone Replacement Therapy (HRT)
Republic Spine and Pain
- PRP Therapy
- IV Therapy
- Ketamine Therapy
- Arthritis Treatment
- Migraine Treatment
Wild Fig Functional Medicine
- IV Therapy
- IV Hydration
- Acne Treatment
- Migraine Treatment
- Peptide Therapy
Regulatory context
A note on Texas's migraine treatment rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
Texas Medical Practice Act (Tex. Occ. Code Title 3, Subtitle B)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
Texas Psychologists Licensing Act (Tex. Occ. Code Chapter 501)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope. -
Texas Deceptive Trade Practices Act (Tex. Bus. & Com. Code Chapter 17)
Supports attorney general action against deceptive medical device advertising.
The Texas Medical Board investigates TMS clinics for supervision lapses, corporate practice violations, and off-label marketing. Texas enforces a strict corporate practice of medicine doctrine, typically requiring Professional Association or Professional Limited Liability Company structures for clinical ownership. The Texas attorney general enforces the Deceptive Trade Practices Act against misleading medical device advertising, including neurofeedback cure claims. Commercial insurers and Texas Medicaid typically require documented treatment-resistant depression before covering TMS for major depressive disorder.